Examkin

Question

Difficulty: MediumGeneral Internal Medicine

For each patient presentation describing a new diagnosis of primary hypertension with specific comorbidities, select the most appropriate preferred initial antihypertensive medication class.

  • A 62-year-old female with a recent dual-energy x-ray absorptiometry scan indicating significant bone mineral density loss.Thiazide diuretic
  • A 55-year-old male with chronic kidney disease and a urine albumin-to-creatinine ratio of 400 mg/g.Angiotensin-converting enzyme (ACE) inhibitor
  • A 45-year-old female who reports frequent, painful episodes of digital pallor and cyanosis when exposed to cold environments.Dihydropyridine calcium channel blocker
  • A 50-year-old male with a history of an anterior wall myocardial infarction three months ago and a left ventricular ejection fraction of 40%.Beta-adrenergic antagonist

Answer

Osteoporosis is treated with a Thiazide diuretic; CKD with albuminuria is treated with an ACE inhibitor; Raynaud phenomenon is treated with a Dihydropyridine calcium channel blocker; and prior MI is treated with a Beta-adrenergic antagonist.
Each patient's presentation includes a specific comorbidity that dictates a preferred antihypertensive class based on secondary therapeutic benefits and established mortality reduction guidelines.

Step-by-Step Solution

1
Identify the primary compelling indication or comorbidity in each patient's presentation.
Patient 1 has osteoporosis. Patient 2 has CKD with overt albuminuria. Patient 3 has Raynaud phenomenon. Patient 4 has a prior myocardial infarction with reduced ejection fraction.
Current hypertension guidelines recommend tailoring initial medical therapy based on specific comorbid conditions to maximize therapeutic benefit.
2
Match each identified comorbidity to the antihypertensive class that provides the most advantageous secondary benefit or mortality reduction.
Osteoporosis benefits from thiazides due to calcium retention. CKD with albuminuria requires ACE inhibitors for renoprotection. Raynaud phenomenon improves with the vasodilatory effects of dihydropyridines. A prior MI requires beta-blockers to reduce cardiac workload and improve survival.
Selecting the optimal pharmacological agent requires synthesizing the diagnosis with the pleiotropic effects of the medication.

Key Concept

Tailoring initial antihypertensive therapy based on compelling clinical indications and patient-specific comorbidities.
Rate this question

Topics

General Internal Medicine

More questions from this topic